Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?

Core Viewpoint - CVS Health has shown significant stock performance recently, with a +27.9% return over the past month, outperforming the S&P 500 composite's +1.1% and the Zacks Retail - Pharmacies and Drug Stores industry's +24.9% [2] Earnings Estimates - CVS Health is expected to report earnings of $0.89 per share for the current quarter, reflecting a year-over-year decline of -58$5.18, indicating a -40.7% change year-over-year [5] - For the next fiscal year, the consensus earnings estimate is $5.97, which represents a +15.3$97.06 billion, showing a year-over-year increase of +3.5%. For the current and next fiscal years, the sales estimates are $372.16 billion and$386.77 billion, reflecting +4% and +3.9% changes, respectively [9] Last Reported Results - In the last reported quarter, CVS Health achieved revenues of $95.43 billion, a +6.3$1.09, down from $2.21 a year ago. The revenue exceeded the Zacks Consensus Estimate by +2.75%, and the EPS surprise was +1.87% [11] Valuation - CVS Health is graded A in the Zacks Value Style Score, indicating that it is trading at a discount compared to its peers [15]